Syncytin immunoreactivity in colorectal cancer: Potential prognostic impact

Cancer Letters

Volumn 280, Issue 1, 2009, Pages 44-49

  Larsen, Julie Mou ^a   Christensen, Ib Jarle ^b   Nielsen, Hans Jørgen ^c   Hansen, Ulla ^c   Bjerregaard, Bolette ^a   Talts, Jan Fredrik ^a   Larsson, Lars Inge ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Colorectal carcinoma; Immunocytochemistry; Overall survival; Retroviral proteins; Syncytin

Indexed keywords

ENVELOPE PROTEIN; SYNCYTIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE PRODUCTS, ENV; HUMANS; MALE; MIDDLE AGED; PREGNANCY PROTEINS; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RETROVIRIDAE; TUMOR MARKERS, BIOLOGICAL;

EID: 67349242463     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.02.008     Document Type: Article

References (18)

1. Blond J.L., Lavillette D., Cheynet V., Bouton O., Oriol G., Chapel-Fernandes S., Mandrand B., Mallet F., and Cosset F.L. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J. Virol. 74 (2000) 3321-3329
2. Mi S., Lee X., Li X., Veldman G.M., Finnerty H., Racie L., LaVallie E., Tang X.Y., Edouard P., Howes S., Keith Jr. J.C., and McCoy J.M. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403 (2000) 785-789
3. Bjerregaard B., Holck S., Christensen I.J., and Larsson L.I. Syncytin is involved in breast cancer-endothelial cell fusions. Cell. Mol. Life Sci. 63 (2006) 1906-1911
4. Mangeney M., Renard M., Schlecht-Louf G., Bouallaga I., Heidmann O., Letzelter C., Richaud A., Ducos B., and Heidmann T. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc. Natl. Acad. Sci. USA 104 (2007) 20534-20539
5. Antony J.M., van Marle G., Opii W., Butterfield D.A., Mallet F., Yong V.W., Wallace J.L., Deacon R.M., Warren K., and Power C. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 7 (2004) 1088-1095
6. Strick R., Ackermann S., Langbein M., Swiatek J., Schubert S.W., Hashemolhosseini S., Koscheck T., Fasching P.A., Schild R.L., Beckmann M.W., and Strissel P.L. Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral syncytin-1 and regulated by TGF-beta. J. Mol. Med. 85 (2007) 23-38
7. Blaise S., de Parseval N., Benit L., and Heidmann T. Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc. Natl. Acad. Sci. USA 100 (2003) 13013-13018
8. Oren-Suissa M., and Podbilewicz B. Cell fusion during development. Trends Cell Biol. 17 (2007) 537-546
9. Lavillette D., Marin M., Ruggieri A., Mallet F., Cosset F.L., and Kabat D. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J. Virol. 76 (2000) 6442-6452
10. Esnault C., Priet S., Ribet D., Vernochet C., Bruls T., Lavialle C., Weissenbach J., and Heidmann T. A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2. Proc. Natl. Acad. Sci. USA 105 (2008) 17532-17537
11. Larsson L.I., Holck S., and Christensen I.J. Prognostic role of syncytin expression in breast cancer. Human Pathol. 38 (2007) 726-731
12. Harris H., Miller O.J., Klein G., Worst P., and Tachibana T. Suppression of malignancy by cell fusion. Nature 223 (1969) 363-368
13. Harris H. The analysis of malignancy by cell fusion: the position in 1988. Cancer Res. 48 (1988) 3302-3306
14. Stanbridge E.J. Suppression of malignancy in human cells. Nature 260 (1976) 17-20
15. Wiener F., Klein G., and Harris H. The analysis of malignancy by cell fusion. V. Further evidence of the ability of normal diploid cells to suppress malignancy. J. Cell. Sci. 15 (1974) 177-183
16. Kohler G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
17. Pawelek J.M., and Chakraborty A.K. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat. Rev. Cancer 8 (2008) 377-386
18. Duelli D.M., Padilla-Nash H.M., Berman D., Murphy K.M., Ried T., and Lazebnik Y. A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr. Biol. 17 (2007) 431-437